Recombinant Zoster Vaccination May Reduce Dementia Risk in Older Adults

1. In this target trial emulation, receipt of the recombinant zoster vaccine (RZV) was associated with a reduced risk of dementia among older adults admitted to skilled nursing facilities. 2. The association was more pronounced among women and among individuals who had not previously received the live attenuated herpes zoster vaccine. Evidence Rating Level: 2 […] The post Recombinant Zoster…